MODAFINIL
NARCOLEPSY SYNDROME·+2
KARALEX PHARMA,
Indication
Narcolepsy syndrome
Narcolepsy syndrome is a chronic neurological disorder of central hypersomnolence that impairs the brain's ability to regulate normal sleep-wake cycles. Read more about Narcolepsy syndrome
174 drugs 96 manufacturers
Drugs that treat it
Common Narcolepsy syndrome therapies.
DEXTROAMPHETAMINE SULFATE
AMPHETAMINES/ANOREXIANTS/STIMULANTS·ATTENTION-DEFICIT HYPERACTIVITY DISORDER·+1
AUROBINDO PHARM
DEXTROAMPHETAMINE SULFATE
AMPHETAMINES/ANOREXIANTS/STIMULANTS·ATTENTION-DEFICIT HYPERACTIVITY DISORDER·+1
TALEC PHARMA
MODAFINIL
AMPHETAMINES/ANOREXIANTS/STIMULANTS·NARCOLEPSY SYNDROME·+2
APOTEX CORP
AMPHETAMINE SALT COMBO (dextroamphetamine sulf-saccharate/amphetamine sulf-aspartate)
AMPHETAMINES/ANOREXIANTS/STIMULANTS·ATTENTION-DEFICIT HYPERACTIVITY DISORDER·+1
AUROBINDO PHARM
MODAFINIL
AMPHETAMINES/ANOREXIANTS/STIMULANTS·NARCOLEPSY SYNDROME·+2
INGENUS PHARMAC
DEXTROAMPHETAMINE SULFATE ER (dextroamphetamine sulfate)
ATTENTION-DEFICIT HYPERACTIVITY DISORDER·+1
ACTAVIS PHARMA,
METHYLPHENIDATE HCL
ATTENTION-DEFICIT HYPERACTIVITY DISORDER·+1
CARACO PHARM
PROCENTRA (dextroamphetamine sulfate)
ATTENTION-DEFICIT HYPERACTIVITY DISORDER·+1
INDEPENDENCE PH
Filter & compare in the drug finder →Opens the drug finder with Narcolepsy syndrome preselected.
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonNarcolepsy syndrome is a chronic neurological disorder of central hypersomnolence that impairs the brain's ability to regulate normal sleep-wake cycles.
It typically manifests in adolescents and young adults, affecting the central nervous system through disrupted sleep architecture and rapid-onset rapid eye movement (REM) sleep.
Clinically, it is defined by persistent excessive daytime sleepiness and irresistible sleep attacks, frequently accompanied by cataplexy, sleep paralysis, hypnagogic or hypnopompic hallucinations, and fragmented nighttime sleep.
Pathophysiologically, the primary form involves an autoimmune-mediated loss of orexin- (hypocretin-) producing neurons in the lateral hypothalamus, leading to severe deficiency of this wake-promoting neuropeptide.
- medlineplus.gov
Narcolepsy syndrome is a chronic neurological disorder of central hypersomnolence that impairs the brain's ability to regulate normal sleep-wake cycles
- mdpi.com
Narcolepsy syndrome is a chronic neurological disorder of central hypersomnolence that impairs the brain's ability to regulate normal sleep-wake cycles
- medlineplus.gov
It typically manifests in adolescents and young adults, affecting the central nervous system through disrupted sleep architecture and rapid-onset rapid eye movement (REM) sleep
- nih.gov
It typically manifests in adolescents and young adults, affecting the central nervous system through disrupted sleep architecture and rapid-onset rapid eye movement (REM) sleep Clinically, it is defined by persistent excessive daytime sleepiness and irresistible sleep attacks, frequently accompanied by cataplexy, sleep paralysis, hypnagogic or hypnopompic hallucinations, and fragmented nighttime sleep Pathophysiologically, the primary form involves an autoimmune-mediated loss of orexin- (hypocre...
- narcolepsynetwork.org
It typically manifests in adolescents and young adults, affecting the central nervous system through disrupted sleep architecture and rapid-onset rapid eye movement (REM) sleep Pathophysiologically, the primary form involves an autoimmune-mediated loss of orexin- (hypocretin-) producing neurons in the lateral hypothalamus, leading to severe deficiency of this wake-promoting neuropeptide
- nih.gov
Clinically, it is defined by persistent excessive daytime sleepiness and irresistible sleep attacks, frequently accompanied by cataplexy, sleep paralysis, hypnagogic or hypnopompic hallucinations, and fragmented nighttime sleep
- ccjm.org
Clinically, it is defined by persistent excessive daytime sleepiness and irresistible sleep attacks, frequently accompanied by cataplexy, sleep paralysis, hypnagogic or hypnopompic hallucinations, and fragmented nighttime sleep
- nih.gov
Pathophysiologically, the primary form involves an autoimmune-mediated loss of orexin- (hypocretin-) producing neurons in the lateral hypothalamus, leading to severe deficiency of this wake-promoting neuropeptide
Personalize your experience
Follow Narcolepsy syndrome and get updates as they land.
Create a free account
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.